US FDA approves Pegintron for treatment-failed hepatitis C patients
16 March 2009
Katie McQue
Please Login to read the full article.
16 March 2009
Katie McQue
katie.mcque@informa.com
Schering-Plough's Pegintron (peginterferon alfa-2b) has become the first pegylated interferon to be approved by the US FDA in combination with ribavirin, for patients with hepatitis C who have previously had an unsuccessful response to interferon therapy, or who have experienced a relapse.
"Based...
Please Login to read the full article.
RELATED CONTENT
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
